![Ronald Aldridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ronald Aldridge worked as a Senior Director of Investor Relations at PAREXEL International Corp.
from 2016 to 2017.
He also worked as the Head of Investor Relations at The Nassau Cos.
of New York, Inc. and as an Investor Relations Contact at Constellation Pharmaceuticals, Inc.
Eerdere bekende functies van Ronald Aldridge
| Bedrijven | Functie | Einde |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Investor Relations Contact | 01-10-2017 |
| CONSTELLATION PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| THE PHOENIX COMPANIES, INC. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
The Nassau Cos. of New York, Inc.
 The Nassau Cos. of New York, Inc. Multi-Line InsuranceFinance Operates as a holding company with interest in providing annuities, life and health insurance services | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
